Congenital heart disease (CHD) is one of the most common risk factors for infective endocarditis. However, it is rare to find a CHD patient complicated by isolated pulmonary valve endocarditis. Here, we report an adult patient with congenital heart disease complicated by native pulmonary valve endocarditis who underwent a mechanical valve replacement. We also review previous literature to examine key points in the treatment of such patients.
We conducted an operation of debridement of infective endocarditis, pulmonary valve replacement (PVR), ventricular septal defect repair, right ventricular outflow tract dredge and tricuspid annuloplasty under general anesthesia and hypothermic cardiopulmonary bypass. The patient was intubated with a single lumen endotracheal tube, and hemodynamics was monitored by a swan-ganz catheter. Following median careful re-sternotomy with a swing saw, aorto-bicaval cannulation was conducted to establish cardiopulmonary bypass (CPB). After the establishment of CPB, the heart was opened. Verrucous vegetations were found on the pulmonary valve and debrided completely, and a CarboMedics 25mm (A1-025) Futaba mechanical valve was chosen to replace the valve (Figure 3) . A peripheral membranous ventricular septal defect of 2.0 × 2.5cm2 was probed and repaired with Gore-Tex patch. RVOT narrowed by fibrous annulus was dredged and resected. Mild prolapse with regurgitation of tricuspid leaflets was observed, and a concomitant tricuspid valvuloplasty was completed.
After the operation, the patient recovered uneventfully, and laboratory studies, TTE (Figure 1c, 1d) , and a pulmonary CTA ( Figure 4 ) were performed before her discharge and showed no abnormalities. A one year 3 month follow-up was conducted, which showed that the patient was in good condition without any symptoms. TTE and chest X-ray also showed no abnormalities.
DISCUSSION
The patient has been diagnosed with CHD since childhood, and we suspect that the abnormalities of hemodynamics caused by stenosis of the RVOT and dilation of the pulmonary artery contributed to the growth of vegetation. A review of the literature found 7 classic case reports of CHD complicated by pulmonary valve endocarditis (Table 1) . However, there are no previous reports of a non-intravenous drug user with CHD complicated by isolated native pulmonary endocarditis and treated with a mechanical valve replacement, to our knowledge.
Besides the classic symptoms of endocarditis, such as fever, anemia weight loss and heart murmur, the right-sided endocarditis has peculiar respiratory symptoms, predisposing to misdiagnosis. In this case, the patient also had respiratory symptoms of cough, chest pain and dyspnea. Most patients in the cases we reviewed have respiratory symptoms of dyspnea, Because patients with right sided endocarditis often have a better prognosis than those with left sided endocarditis, clinicians tend to be more conservative with surgery for patients with pulmonary endocarditis. However, when conservative treatment is ineffective or patients have concomitant structural heart disease, it is necessary to conduct a surgery. Deng and colleagues [Deng 2013 ] reported 4 cases of pulmonary valve endocarditis undergoing surgical valve repair without replacement. PVR is less seen in clinics than other valve replacements because of less incidence of pulmonary endocarditis, better prognosis of pulmonary regurgitation, as well as the higher chance of embolism after PVR. During the operation, we found that the patient's pulmonary valve had been badly destroyed, which required a prosthetic replacement. Prostheses used in PVR at present can be classified into homograft valve-conduit, biological valve, and mechanical valve. These three types of prosthesis have their own pros and cons. According to Delahaye et al. [Delahaye 2014 ], patients undergoing bioprosthetics replacement have higher in-hospital and 1-year death rates, but his research was focused on bicuspid and aortic valves rather than the pulmonary valve. The author attributed this to patient characteristics rather than to valve dysfunction.
Considering economics, recurrence risk of IE, and the age of our patient, we made the decision to complete a mechanical valve replacement. In terms of mechanical PVR, anticoagulation therapy is of paramount importance. Sadeghpour et al. [Sadeghpour 2014 ] reported 38 patients who underwent mechanical PVR, and 7 of them (18%) had malfunctioning pulmonary prostheses because of inadequate anticoagulation therapy. It is recommended that INR be controlled at approximately 3.0. We strictly controlled the INR at 2.8 and the follow-up results showed an absence of thromboembolism.
CONCLUSION
In conclusion, this report highlights three key points. First, even though pulmonary valve endocarditis is relatively rare clinically, physicians should not neglect the possibility of endocarditis when they encounter a patient with respiratory symptoms. Second, a mechanical valve can also be chosen in PVR. And finally, a more rigorous anticoagulation plan must be administered when a mechanical valve replacement is performed on the pulmonary valve.
